Name | Mirikizumab |
---|
Description | Mirikizumab (LY3074828) is a humanized IgG4 monoclonal antibody targets the p19 subunit of interleukin 23. Mirikizumab can be used for the research of ulcerative colitis[1]. |
---|---|
Related Catalog | |
References |
No Any Chemical & Physical Properties |